These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1890625

  • 1. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
    Bergman J, Madras BK, Spealman RD.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [Abstract] [Full Text] [Related]

  • 3. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    Bergman J, Rosenzweig-Lipson S, Spealman RD.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795
    [Abstract] [Full Text] [Related]

  • 5. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM, Bergman J.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [Abstract] [Full Text] [Related]

  • 6. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1039-46. PubMed ID: 8099614
    [Abstract] [Full Text] [Related]

  • 7. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 8. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):237-41. PubMed ID: 7988649
    [Abstract] [Full Text] [Related]

  • 9. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 10. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 13; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 11. Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jun 13; 265(3):1387-91. PubMed ID: 8099621
    [Abstract] [Full Text] [Related]

  • 12. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jan 13; 264(1):221-5. PubMed ID: 8093726
    [Abstract] [Full Text] [Related]

  • 13. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys.
    Gasior M, Paronis CA, Bergman J.
    J Pharmacol Exp Ther; 2004 Jan 13; 308(1):249-59. PubMed ID: 14563783
    [Abstract] [Full Text] [Related]

  • 14. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA, Widzowski DV, Newland MC.
    J Pharmacol Exp Ther; 1989 Sep 13; 250(3):800-8. PubMed ID: 2789282
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ, Caine SB.
    J Pharmacol Exp Ther; 2005 Feb 13; 312(2):733-41. PubMed ID: 15494551
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.
    Howell LL, Byrd LD.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):178-85. PubMed ID: 1677037
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes.
    Spealman RD, Bergman J, Madras BK, Melia KF.
    J Pharmacol Exp Ther; 1991 Sep 01; 258(3):945-53. PubMed ID: 1679852
    [Abstract] [Full Text] [Related]

  • 18. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    Platt DM, Rowlett JK, Spealman RD.
    J Pharmacol Exp Ther; 2000 Jun 01; 293(3):1017-26. PubMed ID: 10869406
    [Abstract] [Full Text] [Related]

  • 19. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
    Witkin JM, Newman AH, Nowak G, Katz JL.
    J Pharmacol Exp Ther; 1993 Oct 01; 267(1):266-74. PubMed ID: 7901394
    [Abstract] [Full Text] [Related]

  • 20. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL.
    Eur J Pharmacol; 2004 Feb 23; 486(3):273-80. PubMed ID: 14985049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.